The Effect of Levothyroxine on Serum Levels of Interleukin 10 and Interferon-gamma in Rat Model of Multiple Sclerosis
- PMID: 28989911
- PMCID: PMC5627569
- DOI: 10.4103/abr.abr_267_16
The Effect of Levothyroxine on Serum Levels of Interleukin 10 and Interferon-gamma in Rat Model of Multiple Sclerosis
Abstract
Background: There is an increase in inflammatory and a reduction in anti-inflammatory cytokines in multiple sclerosis (MS). Considering the role of thyroid hormones in the development and regulation of both neural and immune systems, the aim of this study was to evaluate the effects of levothyroxine on serum concentrations of interleukin-10 (IL-10) and interferon gamma (IFN-γ) in animal models of MS.
Materials and methods: To induce demyelination in male Wistar rats, lysolecithin was injected into the optic chiasm. Then levothyroxine was injected intraperitoneally (20, 50, and 100 μg/kg) for 21 days. Serum levels of cytokines were measured by enzyme-linked immunosorbent assay at 7, 14, and 21 days after that.
Results: The results showed that injection of lysolecithin to the optic chiasm only increased serum concentrations of IL-10 compared to the sham group (P < 0.05) at 7th day, but this increase was prevented by all doses of levothyroxine. IFN-γ was decreased significantly (P < 0.001) 21 days after. Comparing to the sham group at all sampling time and with respect to the MS group at the days 7 and 21, levothyroxine decreased serum concentrations of IFN-γ significantly.
Conclusion: The results showed that thyroid hormones probably could produce protective effects against induced demyelination through affecting immune responses.
Keywords: Interferon-gamma; interleukin-10; levothyroxine; multiple sclerosis.
Conflict of interest statement
There are no conflicts of interest.
Figures


Similar articles
-
Effects of Levothyroxine on Visual Evoked Potential Impairment Following Local Injections of Lysolecithin into the Rat Optic Chiasm.Int J Prev Med. 2018 Feb 8;9:18. doi: 10.4103/ijpvm.IJPVM_418_16. eCollection 2018. Int J Prev Med. 2018. PMID: 29541433 Free PMC article.
-
The Effects of Pentoxifylline on Serum Levels of Interleukin 10 and Interferon Gamma and Memory Function in Lipopolysaccharide-induced Inflammation in Rats.Adv Biomed Res. 2017 Aug 31;6:110. doi: 10.4103/abr.abr_49_17. eCollection 2017. Adv Biomed Res. 2017. PMID: 28904938 Free PMC article.
-
Clinical and laboratory study of pro-inflammatory and antiinflammatory cytokines in women with multiple sclerosis.Folia Med (Plovdiv). 2011 Apr-Jun;53(2):29-35. doi: 10.2478/v10153-010-0034-x. Folia Med (Plovdiv). 2011. PMID: 21797104 Clinical Trial.
-
Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.Acta Neurol Scand Suppl. 1994;158:1-58. Acta Neurol Scand Suppl. 1994. PMID: 7732782
-
The effects of interleukin-10 depletion in vivo on the immune response to Porphyromonas gingivalis in a murine model.J Periodontol. 2001 Nov;72(11):1527-34. doi: 10.1902/jop.2001.72.11.1527. J Periodontol. 2001. PMID: 11759864
Cited by
-
Fingolimod and changes in hematocrit, hemoglobin and red blood cells of patients with multiple sclerosis.Am J Clin Exp Immunol. 2019 Aug 15;8(4):27-31. eCollection 2019. Am J Clin Exp Immunol. 2019. Retraction in: Am J Clin Exp Immunol. 2019 Oct 15;8(5):54. PMID: 31497380 Free PMC article. Retracted.
-
Effect of fingolimod on white blood cell, lymphocyte and neutrophil counts in MS patients.Am J Clin Exp Immunol. 2019 Apr 15;8(2):9-15. eCollection 2019. Am J Clin Exp Immunol. 2019. Retraction in: Am J Clin Exp Immunol. 2019 Oct 15;8(5):53. PMID: 31131156 Free PMC article. Retracted.
-
Evaluation of the Relative Frequency of Epstein-Barr Virus Infection in Patients with Recurrent Breast Cancer Compared with Patients with Nonrecurrent Breast Cancer.Adv Biomed Res. 2023 Feb 25;12:34. doi: 10.4103/abr.abr_381_21. eCollection 2023. Adv Biomed Res. 2023. PMID: 37057233 Free PMC article.
-
Neuroprotective effects of levothyroxine on cognition deficits and memory in an experimental model of Huntington's disease in rats: An electrophysiological study.Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5939-5951. doi: 10.1007/s00210-024-03006-w. Epub 2024 Feb 19. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38372755
-
Evaluation of PD-L1 antigen expression using immunohistochemistry technique in medullary thyroid carcinoma samples.Int J Physiol Pathophysiol Pharmacol. 2023 Feb 15;15(1):12-20. eCollection 2023. Int J Physiol Pathophysiol Pharmacol. 2023. PMID: 36936544 Free PMC article.
References
-
- Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005;23:683–747. - PubMed
-
- Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci. 2002;3:705–14. - PubMed
-
- Stangel M, Hartung HP. Remyelinating strategies for the treatment of multiple sclerosis. Prog Neurobiol. 2002;68:361–76. - PubMed
-
- Calzà L, Fernandez M, Giardino L. Cellular approaches to central nervous system remyelination stimulation: Thyroid hormone to promote myelin repair via endogenous stem and precursor cells. J Mol Endocrinol. 2010;44:13–23. - PubMed
-
- Lachapelle F, Avellana-Adalid V, Nait-Oumesmar B, Baron-Van Evercooren A. Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. Mol Cell Neurosci. 2002;20:390–403. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources